Cargando…

Responsivity and Reproducibility of Sputum Inflammatory Biomarkers During COPD Exacerbation and Stable Phases – A Pilot Study

INTRODUCTION: There is a great interest to identify airway biomarkers to evaluate the potential and efficacy of anti-inflammatory therapeutic interventions. In this pilot study, we compared cytokine mRNA and protein levels of IL-6, IL-8, CCL2, CCL4, and TNF-α, as well as LTB-4 expression regarding t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ditz, B, Kistemaker, L E M, van den Berge, M, Vonk, J M, Gosens, R, Kerstjens, H A M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590961/ https://www.ncbi.nlm.nih.gov/pubmed/34785892 http://dx.doi.org/10.2147/COPD.S326081

Ejemplares similares

The sputum transcriptome better predicts COPD exacerbations after the withdrawal of inhaled corticosteroids than sputum eosinophils
por: Ditz, Benedikt, et al.
Publicado: (2021)

Sputum microbiome profiling in COPD: beyond singular pathogen detection
por: Ditz, Benedikt, et al.
Publicado: (2020)

Reproducibility of fluid-phase measurements in PBS-treated sputum supernatant of healthy and stable COPD subjects
por: Wang, Fengyan, et al.
Publicado: (2019)

Sputum Cytokine Profiling in COPD: Comparison Between Stable Disease and Exacerbation
por: Barta, Imre, et al.
Publicado: (2022)

Haematological and Inflammatory Biomarkers Among Stable COPD and Acute Exacerbations of COPD Patients
por: Ramya, Priya A., et al.
Publicado: (2023)

Real-life data on antibiotic prescription and sputum culture diagnostics in acute exacerbations of COPD in primary care
por: Bathoorn, Erik, et al.
Publicado: (2017)

Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbation
por: Bathoorn, Erik, et al.
Publicado: (2009)

Sputum Bacterial and Fungal Dynamics during Exacerbations of Severe COPD
por: Su, Jin, et al.
Publicado: (2015)

Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients
por: Tangedal, Solveig, et al.
Publicado: (2019)

Bacterial flora in the sputum and comorbidity in patients with acute exacerbations of COPD
por: Boixeda, Ramon, et al.
Publicado: (2015)

Validation of the breathlessness, cough and sputum scale to predict COPD exacerbation
por: DeVries, Rebecca, et al.
Publicado: (2016)

Influence of Cell Quality on Inflammatory Biomarkers in COPD Sputum Supernatant
por: Pedersen, Frauke, et al.
Publicado: (2021)

Altered Gene Expression in Blood and Sputum in COPD Frequent Exacerbators in the ECLIPSE Cohort
por: Singh, Dave, et al.
Publicado: (2014)

The Most Common Detected Bacteria in Sputum of Patients with the Acute Exacerbation of COPD
por: Cukic, Vesna
Publicado: (2013)

Sputum PGP is reduced by azithromycin treatment in patients with COPD and correlates with exacerbations
por: O'Reilly, Philip J, et al.
Publicado: (2013)

Characteristics of the sputum microbiome in COPD exacerbations and correlations between clinical indices
por: Su, Linfan, et al.
Publicado: (2022)

A Sputum 6 Gene Expression Signature Predicts Inflammatory Phenotypes and Future Exacerbations of COPD
por: Baines, Katherine J, et al.
Publicado: (2020)

Correlation between fractional exhaled nitric oxide and sputum eosinophilia in exacerbations of COPD
por: Gao, Jie, et al.
Publicado: (2017)

MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation
por: Mercer, PF, et al.
Publicado: (2005)

Characterization of sputum biomarkers for asthma–COPD overlap syndrome
por: Gao, Jing, et al.
Publicado: (2016)

Acute kidney injury in stable COPD and at exacerbation
por: Barakat, MF, et al.
Publicado: (2015)

The inflammasome pathway in stable COPD and acute exacerbations
por: Faner, Rosa, et al.
Publicado: (2016)

Sputum cell count: biomarkers in the differentiation of asthma, COPD and asthma–COPD overlap
por: Gao, Jie, et al.
Publicado: (2017)

Airways inflammation and treatment during acute exacerbations of COPD
por: Bathoorn, Erik, et al.
Publicado: (2008)

Multi analyte profiling and variability of inflammatory markers in blood and induced sputum in patients with stable COPD
por: Aaron, Shawn D, et al.
Publicado: (2010)

Sputum procalcitonin: a potential biomarker in stable bronchiectasis
por: Good, William, et al.
Publicado: (2021)

Lung microbiome of stable and exacerbated COPD patients in Tshwane, South Africa
por: Goolam Mahomed, T., et al.
Publicado: (2021)

Stability in eosinophil categorisation during subsequent severe exacerbations of COPD
por: Citgez, Emanuel, et al.
Publicado: (2021)

Function-specific IL-17A and dexamethasone interactions in primary human airway epithelial cells
por: Rahmawati, Siti Farah, et al.
Publicado: (2022)

Microparticles in sputum of COPD patients: a potential biomarker of the disease?
por: Lacedonia, Donato, et al.
Publicado: (2016)

Characterization of sputum biomarkers for asthma–COPD overlap syndrome [Erratum]
Publicado: (2017)

Validation of Sputum Biomarker Immunoassays and Cytokine Expression Profiles in COPD
por: Mulvanny, Alex, et al.
Publicado: (2022)

Microbiome balance in sputum determined by PCR stratifies COPD exacerbations and shows potential for selective use of antibiotics
por: Haldar, Koirobi, et al.
Publicado: (2017)

Correlation of Clinical Symptoms and Sputum Inflammatory Markers with Air Pollutants in Stable COPD Patients in Beijing Area
por: Guo, Chenxia, et al.
Publicado: (2020)

Low human beta-defensin-2 levels in the sputum of COPD patients are associated with the risk of exacerbations
por: Feng, Shengchuan, et al.
Publicado: (2023)

Blood Eosinophils and Exhaled Nitric Oxide: Surrogate Biomarkers of Airway Eosinophilia in Stable COPD and Exacerbation
por: Antus, Balazs, et al.
Publicado: (2022)

Novel protein biomarkers for pneumonia and acute exacerbations in COPD: a pilot study
por: Jung, Anna Lena, et al.
Publicado: (2023)

Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study
por: Singh, Dave, et al.
Publicado: (2010)

A short-term mouse model that reproduces the immunopathological features of rhinovirus-induced exacerbation of COPD
por: Singanayagam, Aran, et al.
Publicado: (2015)

COPD exacerbations in general practice: variability in oral prednisolone courses
por: de Vries, Marianne, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_9s6pookcvkdp0ms2fbb1jtnfl0